Company profile: Nanalysis
1.1 - Company Overview
Company description
- Provider of portable benchtop nuclear magnetic resonance (NMR) spectrometers and supporting software for biotech, pharmaceutical, research, and education applications. Offerings include 100 MHz and 60 MHz NMR spectrometers, NMReady-CONNECT for remote control/monitoring, pulse sequence design, time-based kinetics experiments, and IQ/OQ modules for performance validation and regulatory compliance.
Products and services
- 60 MHz Benchtop NMR Spectrometer: Benchtop-scale flagship portable NMR at 60 MHz balancing performance and accessibility for various scientific applications
- NMReady-CONNECT: Workflow-integrated software interface enabling remote control and monitoring of Nanalysis benchtop NMR spectrometers, supporting integration into workflows
- 100 MHz Benchtop NMR Spectrometer: Portable-class compact benchtop NMR at 100 MHz featuring the highest magnetic field for portable use, engineered for research and education across diverse applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nanalysis
PharmaDiagnostics
HQ: Belgium
Website
- Description: Provider of analytical techniques and assay systems to accelerate the drug discovery process, offering human albumin binding, human orosomucoid, membrane, and redox potential assays, plus experimental pKa, experimental log D, P-glycoprotein interaction, and Cytochromes P450 assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaDiagnostics company profile →
SynHelix
HQ: France
Website
- Description: Provider of offerings aimed at breaking the bottleneck of biotherapeutics development by addressing the unsolved DNA constructs supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SynHelix company profile →
Qrons
HQ: United States
Website
- Description: Provider of preclinical biotech solutions developing advanced cell-based therapies and proprietary synthetic hydrogels—injectable, 3D printable polypseudorotaxane hydrogels that inhibit harmful neuronal processes and promote regeneration—and nano tellurium-based compositions to treat infectious diseases, resistant bacteria, sepsis, and neuronal diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qrons company profile →
Femtogenix
HQ: United Kingdom
Website
- Description: Provider of next-generation DNA-interactive payload molecules for antibody-drug conjugates, discovered and developed via a platform that combines proprietary computational chemistry techniques with founder know-how from over 50 years of DNA-targeted drug experience. Founded in 2015.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Femtogenix company profile →
SeqLL
HQ: United States
Website
- Description: Provider of molecule sequencing technology for research and healthcare communities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SeqLL company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nanalysis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nanalysis
2.2 - Growth funds investing in similar companies to Nanalysis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nanalysis
4.2 - Public trading comparable groups for Nanalysis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →